Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/43986
Title: | Oxovanadium(IV) complexes of polypyridyl bases as photocytotoxic and DNA crosslinking agents |
Authors: | Kumar, Arun Dixit, Akanksha Banerjee, Samya Mukherjee, Sanjoy Sahoo, Somarupa Karande, Anjali A Chakravarty, Akhil R |
Keywords: | Bioinorganic chemistry;Photocytotoxicity;Cytotoxicity;DNA crosslinks;DNA cleavage;Vanadium;Polypyridyl bases |
Issue Date: | Mar-2018 |
Publisher: | NISCAIR-CSIR, India |
Abstract: | Dichlorooxovanadium(IV) complexes of polypyridyl bases (B), viz., [VO(B)Cl2] (1 and 2) of N,N,N-donor ligands 2-(2-pyridyl)-1,10-phenanthroline (pyphen in 1) and 3-(pyridin-2-yl)dipyrido[3,2-a:2',3'-c]phenazine (pydppz in 2) have been prepared, and their anticancer activity studied. The complexes show good solubility in most polar solvent and are non-electrolytes. They show 1:1 electrolytic property in 20% aqueous DMF, and 1:2 electrolytic character in 20% aqueous DMF upon photo-irradiation with visible light (400–700 nm). Complex 1 shows DNA crosslinking property on dissociation of the V-Cl bond(s) as ascertained from its DNA melting profile and ethidium bromide displacement assay. The complexes 1 and 2 are photocytotoxic towards HeLa (IC50: 16.9 µM and 0.87 µM respectively) and MCF-7 (IC50: 19.5 µM and 1.4 µM respectively) cancer cells, but exhibit less toxicity in normal embryonic fibroblast 3T3 cells with IC50 values of ~40 and ~25 µM in visible light (400-700 nm) for complexes 1 and 2 respectively. Complex 2 also displays light induced plasmid DNA cleavage activity. The light-induced cellular damage leads to generation of reactive oxygen species followed by apoptotic cell death. |
Page(s): | 409-417 |
ISSN: | 0975-0975(Online); 0376-4710(Print) |
Appears in Collections: | IJC-A Vol.57A(03) [March 2018] |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IJCA 57A(3) 409-417.pdf | 437.92 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.